Member Info for BlahBlahDoh

Investment manager is changing from Gresham House to Harwood Capital.
Company name is changing from Gresham House Strategic to Rockwood Strategic.

Rationale: lower fees, higher net asset value, cooler name

Q3 update shows no surprises, growth continuing as expected.
Quarterly dividend of 21p to be paid on 17 jan, ex div 9 Dec.

I copied and pasted your own words elrico, so not sure why you think the quote is not accurate? Including more context seemed unnecessary since I was narrowly discussing only the specific point quoted. Your defence of that point seems weak to me. You say, for instance, that CF "warned" that the company was profitable on a monthly basis from the last Q4. How can that possibly be construed as a warning? It was obviously intended to signal that finances were improving, and could only lead investors to believe that losses were narrowing - it was more or less impossible to interpret it any other way, and certainly nobody on these boards did. Your claim that "Many retail investors wrongly assumed this meant the company was profitable for the FY" is wishful thinking in support of your argument: virtually no-one here, or elsewhere, predicted a profit, most were discussing how small the loss would be, and you can go back and find many posts discussing that, including mine. Most thought the loss would at least be lower than last years, or lower than at H1. The massively increased loss was a surprise to everyone, not just retail investors, partly because of the repeated "Q4 was profitable" line, with not a single hint that Q3 was catastrophically bad. Yet losses were enormous in Q3 (they must have been more than £6m if Q4 was profitable, i.e. worse than the whole of the previous year). So why was CF only highlighting the financially less significant Q4, over and over again (every month according to you): was he even aware of the reality? Either he wasn't, or he was and said nothing. Either way, that is bad management, and it is the root cause of "The main reason peeps are complaining", namely the resulting, lingering effect on the SP.

Anyway, different opinions are what a discussion board is about, so fair play to you, thanks for posting, and good luck.

"The main reason peeps are complaining is the SP has reversed."
Disagree, main reason peeps complained was the huge disparity between CFs guidance and the shocking increase in losses revealed in last years results. Brutal SP drop was inevitable, it was blatant mismanagement. H1 results show that CF was not wrong about the turnaround, just the messaging and timing, but market uncertainty remains over the real value here, both of the business and the management. Objectively, business looks pretty solid, but earache is reasonable (no, really!) in questioning the source and reliability of estimates for market growth. We need realistic guidance.

Dr Sanjay Gupta, from the states, claims COVID-19 is more deadly in wealthier countries due to compromised immune systems caused by diseases of the wealthy - bad diets, lack of exercise, obesity, diabetes etc. He is also calling for a permanent "defense budget" against pathogens with a similar justification to military budgets. The current virus is now close to killing more Americans than any war in their entire history.

Laura Prieskorn, CEO of Jackson, stated, "With a healthy balance sheet, continued robust annuity sales, and favorable investment returns, our second quarter results position Jackson well for success as an independent, public company. We intend to build on this momentum, pursue profitable growth and deliver on our financial target of $325 -$425 million in capital return to shareholders in our first year as a public company."

https://finance.yahoo.com/news/jackson-financial-announces-second-quarter-122000845.html

Third quarter results are due on November 9th (Tuesday)

"I honestly can’t see how Parsortix can fail "
Most applicants probably feel that way, but there is always the possibility of some unforeseen detail of concern from diligent regulators who are looking at the technology from a different ... angle. The mood music from AN after supplying further requested information was relaxed and confident though, so the signs are positive. Market is being naughty and irrational - what's POLX got to do with it, got to do with it?

"More propaganda. Stop spreading the MSN fake news.
We had 60,000 flu deaths in 2017/18 and 2008 and thats without even opening a stats page."

MrDribbles is wrong about the number of deaths from flu, and wrong about "MSN" too. - in fact the numbers are not really easily available, but his number for 2017/18 is from the US, therefore misleading and irrelevant to the story he is making accusations about, and in 2008 the numbers were estimated around 13,000 in this analysis from the Oxford vaccine group: https://vk.ovg.ox.ac.uk/vk/influenza-flu

So, MrDribbles is guilty of what he accuses "MSN" of: spreading completely false misinformation. The truth is that the Sky news story is reporting on real concerns from health officials about influenza this winter, and the reasons for that concern are credible, it is not "propaganda". Will MrDribbles therefore please retract the utter BS he posted? Thank you so much.

btw, no-one has commented on the additional threat from RSV this winter mentioned in the article - this also tends to highlight the importance and value of ORPHs offerings.

Three days of little nibbles by Schroders. They just can't resist. Naughty.

Up? We don't understand that concept on this board. What is this, witchcraft?

"our dots were reported as the best and cheapest lighting /heating in this area"
I don't think that's correct, although they were candidates at one time. Vertical farms now use purple LEDs, because they are optimum, I believe.

Another example is the Welsh company, CREO, who have successfuly obtained FDA approvals recently:
https://creomedical.com/2020/11/03/us-fda-clearance-for-microblate-fine-device/#:~:text=Creo%20Medical%20Group%20plc%20(AIM,ablation%20device%20MicroBlate%E2%84%A2%20Fine.

We shouldn't discount the possibility of a "disapproval", and a wake up call about that is not necessarily a bad thing, but even such a setback might not stop the momentum apparently gathering behind AGL's technology from other places.

It would be a surprise if they didn't redeem the amount of high coupon debt announced. They would then have the capability to borrow from a stronger capital position at, presumably, lower rates. Maybe sell corporate bonds to Mike's new fans in Asia. Some might question why they've carried high coupons for so long, in a low interest era, but apparently you can't make an omelette without dinosaur eggs ( :

Nothing BTB? We got what other companies can only dream of: a free factory! What do you want, orders too? Some people are just plain greedy

Next trading update due Monday. The last two have seen the SP spike around 5600p. The market seems to expect something different this time, maybe because of concerns over the recent COVID spike in Vietnam and the outbreaks in Chinese cities referred to by Iain Staples? Should be interesting to see how they have coped.

A Nasdaq listing would not just raise capital, and the effect on the share price would be wider than just how they subsequently used the raised capital. For one thing, it would almost certainly qualify for inclusion in various index funds and other instruments, which would tend to drive the share price higher, but more obviously the much greater general US appetite for such stocks would surely value it much higher than the current rating here through sheer pressure from buyers. The SP is obviously not based simply on fundamentals. With regard to progress, listing seems to be dependent upon an endorsement from the FDA, so considerable progress would already be in the bag beforehand, but it really is a separate issue affecting the long term dynamics of the SP rather than the immediate likely re-rating from a listing.

Prudential recently raised money by issuing new shares in Hong Kong. The money is used to improve their capital position by paying off high coupon bonds, thereby redeeming expensive debt, but a side effect is to gain more Asian investors. The price has rallied due to much higher volume, apparently more demand for shares coming from the HK and Singapore markets, where the company is perceived as a growth vehicle, quite different to how it is traditionally viewed on it's primary UK market. Nothing is certain, but the effect of a NASDAQ listing on AGL would likely be similar but much, much stronger?

Vivodots is just a trademark. Nanoco need to demonstrate the validity of their patents otherwise there is no "moat" to the technology and others can steal it like Samsung did. Vivodots are huddled in a castle in the desert, hoping the moat isn't a mirage.

Dealing in the new shares commences in HK, Singapore and London. Long term plan completed, it seems. Woo hoo?

Both Gilstrap and Pelosi were transparent in terms of declaring their partners dealings, and both were later accused of wrongdoing - that's the connection from a journalists and public interest point of view.

The fact Gilstrap's similar behaviour was not picked up for a very long time then was suddenly reported on shortly after the Pelosi story broke may, of course, just be a coincidence. It was mere speculation as to why the press noticed and reported on Gilstrap's actions now. As for "Pelosi's dishonesty", it is not clear what you are referring to, or why it is relevant. The speculation was about the timing of press interest, i.e. what prompted it, because if Samsung were behind it, now doesn't seem like very effective timing for them - earlier or later would seem strategically more beneficial?

52,156 died of Covid last week, 11,379 of them in the States - this first oral treatment from Merck could be a big breakthrough if it really halves the death rate, especially with another spike expected in the winter.
"The pill, which was originally developed to treat influenza, is designed to introduce errors into the genetic code of the virus, preventing it from spreading in the body."
https://www.bbc.co.uk/news/health-58764440

So Invesco singlehandedly sold off 2% of the total shares in issue. Clunk!
Still got those 60K though: keeping the faith, eh?